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Background
The selective pressure of antiretroviral therapy invari-
ably results in the emergence of drug-resistant HIV
variants that acquire mutations which can compromise
the replication capacity of the virus. Recently, we
showed that impaired replication of ritonavir-resistant
HIV can be rescued by cellular activation. Ritonavir-
resistance mutations in HIV protease prevent complete
proteolysis of the Gag polypeptide, and the accumula-
tion of uncleaved capsid-spacer peptide1 (CA-SP1) in
maturing virus particles decreases the ability of HIV to
replicate in human thymocytes and nonactivated cell
lines. We confirmed that ritonavir-resistant HIV repli-
cation was arrested after virus entry but before com-
plete proviral DNA synthesis. Using a functional
genetic screen, we identified the abundant cellular cha-
perone Hsp90 as a host factor that can rescue the
impaired replication of ritonavir-resistant HIV. We
confirmed that Hsp90 expression increases in response
to cellular activation and that pharmacologic inhibition
of Hsp90 blocks HIV replication. Previous work has
shown that altering key residues in structural domains
of the HIV core prevents uncoating of the CA lattice
in an infected cell. The CA mutations render the core
either unstable or too stable, in each case resulting in
abortive HIV replication at the uncoating stage of the
virus life cycle. The nature of our genetic screen was
based on the ability of a host factor to rescue a repli-
cation-impaired HIV isolate with a defective CA mor-
phology. To verify Hsp90 as a potential host factor in
HIV uncoating, we tested its ability to rescue the
impaired replication of HIV with different destabilizing
CA mutations.
Materials and methods
Titrated virus stocks with mutations in different struc-
tural domains of HIV CA were generated. Jurkat T cells
were transduced with WT and mutant Hsp90-expressing
retrovirus and subsequently inoculated with the different
CA mutants. Productive virus replication was monitored
over 8 days.
Results
Although the CA mutants replicated poorly in normal Jur-
kat T cells (0–27% relative to infectivity of WT HIV), they
displayed varying degrees of impairment (32–75% relative
to WT HIV) in PHA-activated human peripheral blood
mononuclear cells and activated Jurkat T cells. Further,
productive replication of several CA mutants were
observed in Jurkat T cells transduced with WT Hsp90.
Conclusions
The ability of CA-mutant HIV to replicate in Hsp90-
transduced Jurkat T cells suggests a potential role for
Hsp90 as an uncoating factor in postentry HIV replica-
tion. The increased expression of Hsp90 in activated T
cells may override the destabilizing effects of CA muta-
tions that arise in response to immune surveillance or
drug therapy.
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